BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 8649410)

  • 1. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein.
    Dimri GP; Nakanishi M; Desprez PY; Smith JR; Campisi J
    Mol Cell Biol; 1996 Jun; 16(6):2987-97. PubMed ID: 8649410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein.
    Buchmann AM; Swaminathan S; Thimmapaya B
    Mol Cell Biol; 1998 Aug; 18(8):4565-76. PubMed ID: 9671466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.
    Lee SJ; Ha MJ; Lee J; Nguyen P; Choi YH; Pirnia F; Kang WK; Wang XF; Kim SJ; Trepel JB
    J Biol Chem; 1998 Apr; 273(17):10618-23. PubMed ID: 9553123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
    Watanabe G; Albanese C; Lee RJ; Reutens A; Vairo G; Henglein B; Pestell RG
    Mol Cell Biol; 1998 Jun; 18(6):3212-22. PubMed ID: 9584162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes.
    Hauck L; Hansmann G; Dietz R; von Harsdorf R
    Circ Res; 2002 Nov; 91(9):782-9. PubMed ID: 12411392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L; La Thangue NB
    Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Timchenko NA; Wilde M; Darlington GJ
    Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
    Alexander K; Hinds PW
    Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
    Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
    Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.